Home/Filings/4/0001140361-18-032189
4//SEC Filing

VAN ASSCHE BENOIT 4

Accession 0001140361-18-032189

CIK 0001012477other

Filed

Jul 10, 8:00 PM ET

Accepted

Jul 11, 5:38 PM ET

Size

10.2 KB

Accession

0001140361-18-032189

Insider Transaction Report

Form 4
Period: 2018-07-09
Transactions
  • Award

    ADSs

    2018-07-09+26,36526,365 total
Holdings
  • Stock Option (right to buy)

    Exercise: $10.51From: 2018-06-28Exp: 2022-06-28ADSs (35,000 underlying)
    35,000
  • Warrants (right to buy)

    Exercise: $13.59From: 2017-08-10Exp: 2020-08-10ADSs (54,026 underlying)
    54,026
  • Warrants (right to buy)

    Exercise: $21.67From: 2016-06-26Exp: 2019-06-26ADSs (54,026 underlying)
    54,026
Footnotes (5)
  • [F1]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
  • [F2]Represents 26,365 restricted ADSs granted under the issuer's Omnibus Incentive Compensation Plan on 07/09/2018; one-third (1/3) of the ADSs will vest on each of the first three anniversaries of the grant date.
  • [F3]Warrants were granted 06/26/2015 but were not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants became exercisable for a 3-year period as to all 54,026 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 2 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro)19.34 per ADS.
  • [F4]Warrants were granted 08/10/2016 but were not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants became exercisable for a 3-year period as to all 54,026 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 2 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro) 12.16 per ADS.
  • [F5]Options became exercisable as to all 35,000 ADSs on the first anniversary of the 06/28/2017 grant date.

Documents

1 file

Issuer

AVADEL PHARMACEUTICALS PLC

CIK 0001012477

Entity typeother

Related Parties

1
  • filerCIK 0001318487

Filing Metadata

Form type
4
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 5:38 PM ET
Size
10.2 KB